News and Media Resources:
2005 Immunization News
December 2005
- December 23, 2005 issue
Errata: Vol. 54, No. RR-16 for the MMWR:
Erratum: Vol. 54, No. RR-16 for the MMWR:
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the U.S.
This report is the first of a two-part statement from the ACIP...and provides updated recommendations to improve prevention of perinatal and early childhood HBV transmission, including implementation of universal infant vaccination beginning at birth, and to increase vaccine coverage among previously unvaccinated children and adolescents. Strategies...- Appendix A: Case Finding and Management of Hepatitis B Surface Antigen (HBsAg)--Positive Persons During Delivery of Vaccination Services
- Appendix B: Immunization Management Issues
- Appendix C: Postexposure Prophylaxis of Persons with Discrete Identifiable Exposures to Hepatitis B Virus (HBV)
- December 23, 2005 issue
Pertussis — United States, 2001-2003
This report summarizes national surveillance data on pertussis reported to CDC during 2001-2003 and focuses on pertussis reported among persons aged 10-19 years before implementation of national recommendations for adolescent pertussis vaccination... - December 16, 2005 issue
Notice to Readers: Ninth Annual Conference on Vaccine Research, May 8-10, 2006
CDC and 10 other national and international agencies and organizations will collaborate with the National Foundation for Infectious Diseases in sponsoring the Ninth Annual Conference on Vaccine Research... - December 16, 2005 issue
Update: Influenza Activity — United States, October 2-December 3, 2005
During October 2-December 3, 2005, low level influenza activity was reported in the United States. This report summarizes U.S. influenza activity since the beginning of the 2005-06 influenza surveillance season and updates the previous summary... - December 9, 2005 issue
FDA Approval of Havrix® (Hepatitis A Vaccine, Inactivated) for Persons Aged 1-18 Years
Previously, pediatric use of Havrix was approved for use in persons aged 2--18 years... - December 9, 2005 issue
Measles -- United States, 2004
This report describes the epidemiology of measles in the U.S. in 2004, documenting the absence of endemic measles and the continued risk for internationally imported measles cases that can result in indigenous transmission... - December 2, 2005 issue
Errata: Vol. 54, No. 47 for the MMWR:
Licensure of a Combined Live Attenuated Measles, Mumps, Rubella, and Varicella Vaccine
On September 6, 2005, the FDA licensed a combined live attenuated measles, mumps, rubella, and varicella (MMRV) vaccine (ProQuad®, Merck & Co., Inc., Whitehouse Station, New Jersey) for use in children aged 12 months-12 years... - December 2005 issue (Vol. 11, No. 12)
Pivotal Role of Dogs in Rabies Transmission, China
The number of dog-mediated rabies cases in China has increased exponentially; the number of human deaths has been high, primarily in poor, rural communities...data from 1950 and 2004, obtained mainly from epidemiologic bulletins published by the Chinese Ministry of Health... - December 2005 issue (Vol. 11, No. 12)
Anthrax in Eastern Turkey, 1992–2004
...investigated animal and human anthrax cases during a 13-year period in eastern Turkey. From 1992 to 2004, a total of 464 animal and 503 human anthrax cases were detected... Anthrax remains a health problem in eastern Turkey, and preventive measures should be taken...
November 2005
- November 25, 2005
Conclusions and Recommendations of the Advisory Committee on Poliomyelitis Eradication — Geneva, Switzerland, October 2005
The second meeting of the ACPE was convened in Geneva, Switzerland, on October 11-12, 2005, to provide WHO and the Global Polio Eradication Initiative with advice on program policies for 1) interrupting wild poliovirus (WPV) transmission worldwide, 2) limiting the international spread of circulating polioviruses, and 3) refining the program of work for eventual cessation of immunization with oral poliovirus vaccine (OPV). This report summarizes the results of that meeting... - November 18, 2005
Immunization Information System Progress — United States, 2004
One of the national health objectives for 2010 is to increase to at least 95% the proportion of children aged <6 years who participate in fully operational, population-based immunization registries (objective no. 14-26)... - e Family Practice News Nov. 15, 2005 (Vol 35, No. 22)
Pandemic Flu Plan Aims to Ramp Up Vaccine Industry (exit)
...The government's plan puts a strong emphasis on developing the capacity to produce influenza vaccine, rather than just focusing on stockpiling... - November 11, 2005
Fifth International Conference on Emerging Infectious Diseases
CDC, the American Society for Microbiology, the Council of State and Territorial Epidemiologists, the Association of Public Health Laboratories, and the World Health Organization will cosponsor the Fifth International Conference on Emerging Infectious Diseases, March 19-22, 2006, at the Marriott Marquis Hotel in Atlanta, GA... - November 4, 2005
Global Measles and Rubella Laboratory Network, January 2004-June 2005
Measles continues to be a leading cause of childhood morbidity and mortality in developing countries and an outbreak threat in the majority of countries. In 2000, measles was considered the fifth leading cause of childhood mortality, and the World Health Organization (WHO) estimated that approximately 777,000 measles-associated deaths occurred worldwide... - e Family Practice News Nov. 1, 2005 (Vol 35, No. 21)
HPV Vaccine Prevents Early Cervical Cancer (exit)
A multinational study of 11,502 young women showed for the first time that a vaccine for human papillomavirus can prevent precancerous cervical lesions and early in situ cervical cancers, Laura A. Koutsky, Ph.D., reported...
October 2005
- October 28, 2005
Import-Associated Measles Outbreak — Indiana, May-June 2005
On May 29, 2005, the Indiana State Department of Health (ISDH) was notified of suspected measles in a female Indiana resident aged 6 years who was hospitalized in Cincinnati, Ohio, where she had been visiting relatives. Serologic analyses performed by the Ohio State Department of Health Laboratory and a private reference laboratory confirmed the diagnosis of measles... - October 21, 2005
Poliovirus Infections in Four Unvaccinated Children — Minnesota, August-October 2005
On October 14, this report was posted as an MMWR Dispatch on the MMWR website. On September 29, 2005, the Minnesota Department of Health (MDH) identified poliovirus type 1 in an unvaccinated, immunocompromised infant girl aged 7 months (the index patient) in an Amish community whose members predominantly were unvaccinated for polio... - October 21, 2005
Influenza Vaccination in Pregnancy: Practices Among Obstetrician-Gynecologists — United States, 2003-04 Influenza Season
To assess understanding of the ACIP recommendations among OB/GYNs, the American College of Obstetricians and Gynecologists (ACOG), with support from CDC, surveyed a national sample of OB/GYNs in May 2004. This report describes the results of that survey... - October 21, 2005
Influenza Vaccination Levels Among Persons Aged >65 Years and Among Persons Aged 18-64 Years with High-Risk Conditions — United States, 2003
Influenza vaccination is an effective tool for preventing hospitalization and death among persons aged 65 years and older, and among persons aged 18-64 years with medical conditions that increase the risk for influenza-related complications... - e Family Practice News Oct. 15, 2005 (Vol 35, No. 20)
CDC Calls on Doctors to Line Up Early for Flu Shots (exit)
Doctors, get your flu shots. Get vaccinated for your patients, do it for yourselves, “do it in droves, just do it,” William Schaffner, M.D., of the NFID, said at a press conference. Julie L. Gerberding, M.D., director of the CDC, stressed the importance of influenza vaccination for everyone. - October 14, 2005
Poliovirus Infections in Four Unvaccinated Children — Minnesota, August-October 2005
On September 29, 2005, the Minnesota Department of Health (MDH) identified poliovirus type 1 in an unvaccinated, immunocompromised infant girl aged 7 months (the index patient) in an Amish community whose members predominantly were unvaccinated for polio... - October 14, 2005
FDA Approval of VAQTA® (Hepatitis A Vaccine, Inactivated) for Children Aged >1 Year
On August 11, 2005, the FDA approved an application of a pediatric/adolescent formulation of VAQTA® for use among persons aged 12 months-18 years. Previously, the pediatric/adolescent formulation of VAQTA was approved for use in persons aged 2-18 years... - October 14, 2005
QuickStats: Rate of Hospitalizations for Pertussis Among Infants Aged <6 Months United States, 1994-1998 and 1999-2003
More than 90% of hospitalizations for pertussis among children aged <2 years occurred in infants aged <6 months, a group too young either to receive vaccination or to have developed adequate protection from vaccination. The pertussis hospitalization rate for infants aged <6 months increased by 20% from 1994-1998 to 1999-2003. - October 14, 2005
Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine -- United States, June-July 2005
As of October 4, 2005, the Vaccine Adverse Event Reporting System (VAERS) received five reports of Guillain-Barré syndrome (GBS) in persons after receipt of MCV4 vaccination. This report describes the clinical and epidemiologic features of these five cases and summarizes preliminary data from ongoing studies... - October 7, 2005
Distribution of Insecticide-Treated Bednets During an Integrated Nationwide Immunization Campaign — Togo, West Africa, December 2004
During December 13-19, 2004, Togo, a West African nation with a population of approximately 5 million, conducted the first-ever nationwide distribution of insecticide-treated bednets (ITNs) for prevention of malaria... - October 6, 2005
Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine—United States, June-July 2005
On January 14, 2005, a quadrivalent (A, C, Y, and W135) meningococcal conjugate vaccine (Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Menactra®, Sanofi-Pasteur, Swiftwater, Pennsylvania) (MCV4) was licensed in the United States... - October 2005 issue (Vol. 11, No. 10)
Poultry-handling Practices during Avian Influenza Outbreak, Thailand
With poultry outbreaks of avian influenza H5N1 continuing in Thailand, preventing human infection remains a priority. We surveyed residents of rural Thailand regarding avian influenza knowledge, attitudes, and practices. Results suggest that public education campaigns have been effective in reaching those at greatest risk, although some high-risk behavior continues...
September 2005
- September 30, 2005
Laboratory Surveillance for Wild and Vaccine-Derived Polioviruses, January 2004-June 2005
A global network of 145 virology laboratories has been established by the World Health Organization (WHO) to support surveillance activities of the Polio Eradication Initiative (PEI). The Global Polio Laboratory Network analyzes stool specimens from patients with acute flaccid paralysis (AFP) and environmental samples for the presence of polioviruses... - September 23, 2005
Errata: Vol. 53, No. 43
In the report, "Influenza and Pneumococcal Vaccination Coverage Among Persons Aged >65 Years and Persons Aged 18-64 Years with Diabetes or Asthma — United States, 2003," errors occurred in Tables 1 and 2... - September 23, 2005
Influenza Vaccination Coverage Among Persons Aged 50-64 Years Enrolled in Commercial Managed Health-Care Plans — United States, 2003-04 & 2004-05 Influenza Seasons
To combat an unexpected shortage of influenza vaccine in the fall of 2004, CDC issued guidance to direct available vaccine supplies to persons in designated priority groups (e.g., persons aged >65 years, persons with certain health conditions, health-care workers, and close contacts of persons at high risk for complications from influenza)... - September 16, 2005
QuickStats: Percentage of Nursing Home Residents Aged >65 Years Who Received Pneumococcal Vaccinations - United States, 1995, 1997, and 1999
From 1995 to 1999, the percentage of nursing home residents aged >65 years who received 23-valent pneumococcal polysaccharide vaccine (PPV23) increased by 58.5%. This increase might be attributable, in part, to a 36% increase in the number of residents living in nursing homes with pneumococcal immunization programs... - September 16, 2005
Erratum: Vol. 54, No. 36 for the MMWR:
Update: Influenza Activity — U.S. and Worldwide, May 22-Sept. 3, 2005, and 2005-06 Season Vaccination Recommendations
Influenza A (H3N2) viruses circulated worldwide, and Influenza A (H1) and B viruses were reported less frequently during May 22-September 3, 2005. In North America, isolates of influenza A (H3N2), A (H1), and influenza B were identified sporadically. This report summarizes influenza activity in the United States and worldwide since the last MMWR update... - September 16, 2005
Direct and Indirect Effects of Routine Vaccination of Children with 7-Valent Pneumococcal Conjugate Vaccine on Incidence of Invasive Pneumococcal Disease --
United States, 1998-2003
Streptococcus pneumoniae (pneumococcus) is a leading cause of pneumonia and meningitis in the United States and disproportionately affects young children and the elderly. In 2000, a 7-valent pneumococcal conjugate vaccine (PCV7) was licensed in the United States for routine use in children aged <5 years... - e Family Practice News Sept. 15, 2005 (Vol 35, No. 18)
Prioritize Flu Shots Until Late October, CDC Says (exit)
As physicians prepared for the upcoming influenza season, the Centers for Disease Control and Prevention recommended that until October 24, vaccination should be restricted to several priority groups. The following groups should receive the trivalent inactivated influenza vaccine (TIV) in this order... - September 9, 2005
Progress Toward Poliomyelitis Eradication — Nigeria, January 2004-July 2005
This report summarizes polio eradication activities and WPV circulation in Nigeria during January 2004-July 2005 and the actions under way to interrupt WPV transmission... - September 2, 2005
Update: Influenza Vaccine Supply and Recommendations for Prioritization During the 2005-06 Influenza Season
The information in this report updates projections of influenza vaccine supply and previous recommendations for priority use of trivalent inactivated influenza vaccine (TIV) during the 2005-06 influenza season...
August 2005
- August 5, 2005
Tiered Use of Inactivated Influenza Vaccine in the Event of a Vaccine Shortage
The United States has experienced disruptions in the manufacture or distribution of inactivated influenza vaccine during three of the last five influenza seasons. Delays in delivery of influenza vaccine or vaccine shortages remain possible, in part, because of inherent time constraints in manufacturing the vaccine, given the annual updating of influenza vaccine strains and uncertainties regarding vaccine supply (including licensure of new vaccine preparations)... - August 5, 2005
Errata: Vol. 54, No. RR-8
In the MMWR Recommendations and Reports, "Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)," the following errors occurred... - e Family Practice News Aug. 1, 2005 (Vol 35, No. 15)
ACIP: Assess All Adults 40 & Older for Varicella Immunity (exit)
All healthy adolescents and adults born in the U.S. after 1965 should be assessed for varicella immunity and vaccinated if susceptible, the CDC's ACIP voted at its summer meeting...
- August 2005 issue (Vol. 11, No. 8)
Influenza A H5N1 Detection
...developed a sensitive and rapid real-time reverse transcription-polymerase chain reaction (RT-PCR) assay to detect influenza A H5N1 virus in clinical samples. This assay was evaluated with samples from H5N1-infected patients and demonstrated greater sensitivity and faster turnaround time than nested RT-PCR... - August 2005 issue (Vol. 11, No. 8)
Influenza A (H3N2) Outbreak, Nepal
In July 2004, an outbreak of influenza A (H3N2) was detected at 3 Bhutanese refugee camps in southeastern Nepal. Hemagglutination inhibition showed that about 40% of the viruses from this outbreak were antigenically distinct from the A/Wyoming/3/03 vaccine strain. Four amino acid differences were observed in most of the 26 isolates compared with the A/Wyoming/3/2003 vaccine strain... - August 2005 issue (Vol. 11, No. 8)
Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
...analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts...
July 2005
- July 29, 2005
Immunization Information System Progress -- United States, 2003
This report summarizes data from CDC's 2003 Immunization Registry Annual Report (IRAR), a survey of IIS grantees in 50 states, five cities, and D.C. that receive funding under section 317b of the Public Health Service Act. The findings of the 2003 IRAR indicate that approximately 44% of U.S. children aged <6 years participated in an IIS... - July 29, 2005
National, State, and Urban Area Vaccination Coverage Among Children Aged 19-35 Months -- United States, 2004
This report summarizes results from the 2004 NIS, which indicated nationwide increases in coverage with at least 1 dose of varicella vaccine, PCV, and the 4:3:1, 4:3:1:3:3, and 4:3:1:3:3:1 vaccine series. These levels represent an important accomplishment by exceeding for the first time the Healthy People 2010 goal of >80% coverage for the 4:3:1:3:3 vaccine series... - July 29, 2005
Erratum: Vol. 54, No. RR-8 for this MMWR:
Prevention and Control of Influenza
This report updates the 2004 recommendations by the ACIP regarding the use of influenza vaccine and antiviral agents (MMWR 2004;53[No. RR-6]:1-40). The 2005 recommendations include new or updated info. regarding 1) vaccination of persons with conditions leading to compromise of the respiratory system; 2) vaccination of healthcare workers; 3) clarification of the role of LAIV in vaccine shortage situations; 4) the 2005-06 trivalent vaccine virus strains...; and 5) the assessment of vaccine supply, timing of influenza vaccination, and prioritization of inactivated vaccine in shortage situations... - July 15, 2005
Erratum: Vol. 54 / Early Release — Prevention and Control of Influenza
In the Early Release, "Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices," an error occurred on page 20, in the section "Vaccination Before October."... - July 13, 2005
Prevention and Control of Influenza: Recommendations of the ACIP
Each year, the ACIP provides updated recommendations on influenza vaccination. This year, the recommendations include information regarding vaccination of persons with conditions leading to compromise of the respiratory system; vaccination of health-care workers... - July 8, 2005
Progress Toward Poliomyelitis Eradication - India, January 2004-May 2005
Since 1988, the global incidence of polio has decreased by more than 99%, and three World Health Organization (WHO) regions (Americas, Western Pacific, and European) have been certified as polio-free... - July 6, 2005
Influenza Vaccines (Trivalent) Added to the VICP
Individuals thought to be injured by the trivalent influenza vaccines are eligible for compensation from the National VICP as of July 1, 2005. This coverage permits people who think that they have been injured by this vaccine to file a claim for compensation. - e Family Practice News July 1, 2005 (Vol 35, No. 13)
"Potent Zoster Vaccine Cuts Shingles Rate by Half"
A potent live zoster vaccine halved the incidence of herpes zoster and reduced its disease burden and complications even more dramatically in a large study of adults aged 60 years and older... - July 1, 2005
Update: Influenza Activity for 2004-05 Season -- U.S. and Worldwide
During the 2004-05 season, influenza A (H1),* A (H3N2), and B viruses cocirculated worldwide, and influenza A (H3N2) viruses predominated... In the U.S., the 2004-05 influenza season peaked in February, was moderate, and was associated predominantly with influenza A (H3N2) viruses... - July 2005 issue (Vol. 11, No. 7)
SARS Vaccine Development
Developing effective and safe vaccines is urgently needed to prevent infection by severe acute respiratory syndrome (SARS)–associated coronavirus (SARS-CoV). The inactivated SARS-CoV vaccine may be the first one available for clinical use because it is easy to generate; however, safety is the main concern... - July 2005 issue (Vol. 2, No. 3)
Are Older Adults Up-to-Date With Cancer Screening and Vaccinations?
Public health organizations in the United States emphasize the importance of providing routine screening for breast cancer, cervical cancer, and colorectal cancer, as well as vaccinations against influenza and pneumococcal disease among older adults...
June 2005
- June 17, 2005
Progress in Measles Control -- Zambia, 1999-2004
This report summarizes progress in measles control in Zambia during 1999-2004, as measured through surveillance data, which demonstrates a marked reduction in measles transmission after the 2003 SIA... - June 3, 2005
Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations
The number of annual hospitalizations for influenza and pneumonia associated with influenza viruses in the United States is estimated at 95,000; however, no state-based or national surveillance system exists to monitor these events in all age groups, and population-based numbers of laboratory-confirmed, influenza hospitalizations are unknown... - June 3, 2005
Assessment of the Distinctions Between Public Health Practice and Research
The Council of State and Territorial Epidemiologists (CSTE) has released a report, Public Health Practice vs. Research: A Report for Public Health Practitioners Including Cases and Guidance for Making Distinctions... - June 3, 2005
New Edition of Health Information for International Travel
CDC announces the availability of the 2005--2006 edition of Health Information for International Travel (i.e., the Yellow Book). This edition, which has been completely revised, updated, and reorganized, now includes references listed at the end of each section...
May 2005
- May 27, 2005
Prevention and Control of Meningococcal Disease
CDC’s Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination of persons aged 11–12 years with the new tetravalent meningococcal polysaccharide-protein conjugate vaccine (MCV4) at the preadolescent healthcare visit (age 11–12 years). This report discusses the new vaccine recommendation, updates previous reports from ACIP concerning prevention and control of meningococcal disease, and provides updated recommendations regarding use of the tetravalent meningococcal polysaccharide vaccine (MPSV4) and on antimicrobial chemoprophylaxis... - May 13, 2005
Hepatitis Awareness Month
May is Hepatitis Awareness Month. In 2003, in the United States, an estimated 61,000 new infections occurred with hepatitis A virus, 73,000 with hepatitis B virus, and 30,000 with hepatitis C virus... - May 2005 issue (Vol. 11, No. 5)
Vaccine–derived Poliovirus, Thailand, 2003
Repoted cases in April of 2003 of poliovirus in spite of the last polio case being reported in April 1997.
April 2005
- April 29, 2005
Progress Toward Interruption of Wild Poliovirus Transmission - Worldwide, January 2004-March 2005
This report describes global efforts to eradicate polio during January 2004-March 2005 and outlines remaining challenges to interrupting transmission in countries where polio remains endemic or transmission has been reestablished... - April 22 , 2005
Summary of Notifiable Diseases, 2003
contains the official statistics, in tabular and graphic form, for the reported occurrence of nationally notifiable diseases in the United States for 2003. The data are final totals for 2002 reported as of June 30, 2004, unless otherwise noted... - April 15, 2005
National Infant Immunization Week - April 24-30, 2005
National Infant Immunization Week (NIIW) is April 24-30, 2005. The theme this year is "Vaccination: an Act of Love. Love Them. Protect Them. Immunize Them." This annual event emphasizes the importance of timely infant and childhood vaccination, one of the most effective ways to protect infants and children from potentially serious diseases...
- April 8, 2005
50th Anniversary of the First Effective Polio Vaccine - April 12, 2005
April 12, 2005, marks the 50th anniversary of the announcement that the polio vaccine, developed by Jonas Salk and his team of scientists at the University of Pittsburgh, worked. "Safe, effective, and potent" were the words used to announce to the world that an effective vaccine had been found against a disease that once paralyzed 13,000-20,000 persons each year in the United States...
- April 8, 2005
Update: Influenza Activity - U.S., 2004-05 Season
This report summarizes influenza activity in the United States during October 3, 2004-March 26, 2005, updates the previous summary, and describes the composition of the 2005-06 influenza vaccine. Influenza activity was moderate in the United States overall, but varied by region. Preliminary data collected through the seven components of the CDC Influenza Surveillance System indicate that national influenza activity peaked in early February...
- April 1 , 2005
Improving Influenza, Pneumococcal Polysaccharide, and Hepatitis B Vaccination Coverage Among Adults Aged <65 Years at High Risk
The Task Force on Community Preventive Services conducted systematic reviews to evaluate the effectiveness of interventions to improve targeted vaccination coverage among adults aged <65 years at high risk when implemented alone and in combination with other interventions. Three targeted vaccinations recommended for populations at risk are addressed in this review: influenza, pneumococcal polysaccharide, and hepatitis B. This report provides additional information about population-based interventions to improve the coverage of influenza, pneumococcal polysaccharide, and hepatitis B vaccines among populations at risk, briefly describes how the reviews were conducted, and provides information that can help in applying the interventions locally...
- April 1 , 2005
Influenza Vaccine Prebooking and Distribution Strategies for the 2005-06 Influenza Season
To plan for the upcoming 2005-06 influenza season, CDC has met with influenza vaccine manufacturers, including those intending to apply for approval to sell in the United States, to develop supply projections and distribution strategies, including prebooking and partial shipment of orders to those customers who prebook...
- April 1 , 2005
Estimated Influenza Vaccination Coverage Among Adults and Children -- U.S., September 1, 2004-January 31, 2005
In response to the unexpected shortfall in the 2004-05 influenza vaccine supply, CDC recommended in October 2004 that vaccine be reserved for persons in certain priority groups. In late December 2004, based on declining demand among these groups, two additional groups were added to the list of vaccination priority groups. This report is based on analysis of data collected during February 1-27, 2005, regarding respondent-reported receipt of influenza vaccination during September 1, 2004-January 31, 2005...
March 2005
- March 25, 2005
Achievements in Public Health: Elimination of Rubella and Congenital Rubella Syndrome -- United States, 1969-2004
In October 2004, CDC convened an independent panel of internationally recognized authorities on public health, infectious disease, and immunization to assess progress toward elimination of rubella and congenital rubella syndrome (CRS) in the United States, a national health objective for 2010. Since rubella vaccine licensure in 1969, substantial declines in rubella and CRS have occurred, and the absence of endemic transmission in the United States is supported by recent data. This report summarizes the history and accomplishments of the rubella vaccination program in the United States and the Western Hemisphere and the challenges posed by rubella for the future...
- March 25, 2005
Progress Toward Poliomyelitis Eradication -- Afghanistan and Pakistan, January 2004-February 2005
Although poliomyelitis remained endemic in only six countries at the end of 2003, a resurgence of polio occurred in 2004, originating in Nigeria and resulting in the export of wild poliovirus into the polio-free countries of western and central Africa. This report summarizes progress toward polio eradication in Afghanistan and Pakistan during January 2004-February 2005 and indicates that, with continued support from national and local leaders, interruption of poliovirus transmission in both countries is feasible by the end of 2005...
- March 25, 2005
Varicella Surveillance in Public Elementary Schools -- Multnomah County, Oregon, 2002-2004
To monitor changes in varicella incidence, Oregon Health Services and Multnomah Education Service District started routine, individual, case-based varicella surveillance in Multnomah County public elementary schools (kindergarten through 5th grade) beginning 2002-03. This report describes the surveillance system, the incidence of varicella, and the results of active surveillance...
- March 25, 2005
Varicella-Related Deaths -- United States, January 2003-June 2004
During 2003 and the first half of 2004, CDC received reports of eight varicella-related deaths. The findings in this report underscore the importance of timely routine vaccination of children aged 12-18 months and catch-up vaccination of older susceptible children and adolescents according to current recommendations and the need for timely and complete national varicella death surveillance...
- March 18, 2005
Compendium of Animal Rabies Prevention and Control, 2005
Rabies is a fatal viral zoonosis and a serious public health problem. The recommendations in this compendium serve as the basis for animal rabies prevention and control programs throughout the United States and facilitate standardization of procedures among jurisdictions, thereby contributing to an effective national rabies-control program. This document is reviewed annually and revised as necessary...
- March 11, 2005
Transmission of Hep B Virus Among Persons Undergoing Blood Glucose Monitoring in Long-Term-Care Facilities -- Mississippi, NC, and Los Angeles County, CA, 2003-2004
Regular monitoring of blood glucose levels is an important component of routine diabetes care. Because of outbreaks of hepatitis B virus (HBV) infections associated with glucose monitoring, CDC and the FDA have recommended since 1990 that fingerstick devices be restricted to individual use. This report describes three recent outbreaks of HBV infection among residents in long-term care facilities that were attributed to shared devices and other breaks in infection-control practices related to blood glucose monitoring...
- March 4 , 2005
Update: Influenza Activity U.S., 2004-05 Season
Influenza activity has increased steadily in the United States since late December 2004 and, as of February 19, 2005, might not have peaked. Laboratory-confirmed influenza infections have been reported from all 50 states. This report summarizes influenza activity during October 3, 2004-February 19, 2005...
- March 4 , 2005
Interventions to Increase Influenza Vaccination of Health-Care Workers - California and Minnesota
Vaccination of healthcare workers (HCWs) has been shown to reduce influenza infection and absenteeism among HCWs, prevent mortality in their patients, and result in financial savings to sponsoring health institutions. However, influenza vaccination coverage among HCWs in the United States remains low. This report describes strategies implemented in three clinical settings that increased the proportion of HCWs who received influenza vaccination...
- March 4, 2005
Vaccination Coverage Among Callers to a State Influenza Hotline - Connecticut, 2004-05 Season
This report summarizes results of a retrospective survey of callers to this influenza vaccine hotline during November 2004...
- March 4 , 2005
Progress in Reducing Measles Mortality - Worldwide, 1999-2003
In the joint Strategic Plan for Measles Mortality Reduction, 2001-2005, the WHO and the United Nations Children's Fund targeted 45 priority countries for implementation of a comprehensive strategy for accelerated and sustained measles mortality reduction. This report updates progress toward this goal and summarizes recent recommendations on methods to estimate global measles mortality...
February 2005
- February 25, 2005
Progress Toward Elimination of Measles and Prevention of Congenital Rubella Infection - European Region, 1990-2004
In 1998, the Regional Committee for European Region (EUR) of the WHO resolved to interrupt indigenous measles transmission by 2007 and reduce the incidence of congenital rubella syndrome (CRS) in the region to fewer than 1 per 100,000 live births by 2010... This report presents data on measles, rubella, and CRS control in EUR during 1990-2004 and summarizes progress halfway through the implementation of the strategic plan...
- February 18, 2005
Hepatitis A Vaccination Coverage Among Children Aged 24-35 Months - United States, 2003
Hepatitis A vaccine was first licensed in the United States in 1995. In 1996, the Advisory Committee on Immunization Practices (ACIP) recommended vaccination of children aged >24 months in populations with the highest incidence of hepatitis A (e.g., American Indian/Alaska Native [AI/AN], Asian/Pacific Islander, and selected Hispanic and religious communities)... This report is the first national analysis of hepatitis A vaccination coverage among children...
- February 11 , 2005
Errata: Volume 54, No. 3
In the report, "Outbreaks of Pertussis Associated with Hospitals - Kentucky, Pennsylvania, and Oregon, 2003," an error occurred in the last sentence on page 70. The text should read: "A recent study that compared azithromycin administered as 10 mg/kg (maximum: 500 mg) on day 1 followed by 5 mg/kg (maximum: 250 mg) on days 2-5 with a 10-day treatment of erythromycin (40 mg/kg/day in 3 divided doses; maximum 1 g/day) demonstrated equivalence between the two treatments (9)." Other corrections are listed...
January 2005
- January 28, 2005
New Vaccine Approved for the Prevention of Meningococcal Disease
(Released January 25, 2005)
- January 28, 2005
Outbreaks of Pertussis Associated with Hospitals - Kentucky, Pennsylvania, and Oregon, 2003
Pertussis outbreaks have been reported in various settings, including sports facilities, summer camps, schools, and healthcare facilities. This report describes three pertussis outbreaks among healthcare workers and patients that occurred in hospitals in Kentucky, Pennsylvania, and Oregon in 2003...
- January 28, 2005
Fatal Case of Pertussis in an Infant - West Virginia, 2004
In December 2004, an infant aged 29 days in West Virginia died from pertussis after exposure to adult family members with probable undiagnosed pertussis. Adolescents and adults, even those previously vaccinated as children, often have disease not recognized as pertussis. This report summarizes results of the West Virginia Department of Health and Human Resources (WVDHHR) case investigation...
- January 28, 2005
Outbreak of Invasive Pneumococcal Disease - Alaska, 2003-2004
In Alaska, statewide laboratory-based surveillance revealed an increase in invasive pneumococcal disease (IPD) in a rural region during 2003-2004. This report summarizes the outbreak, regional trends in serotype-specific pneumococcal carriage, and an assessment of use of standing orders for vaccination. The results of this analysis underscore the preventability of IPD and the importance of vaccination. - January 21, 2005
Notice to Readers: Satellite Broadcast on Epidemiology and Prevention of Vaccine-Preventable Diseases
CDC's NIP and the PHTN will present a live, four-part satellite broadcast series entitled "Epidemiology and Prevention of Vaccine-Preventable Diseases" on February 17 and 24 and March 3 and 10, 2005, from 12:00 noon to 3:30 p.m. EST. The series is intended for physicians, nurses, nurse practitioners, physician assistants, pharmacists, residents, medical and nursing students, and colleagues who either administer vaccinations or set policy in their workplaces.
- January 21, 2005
Erratum: Vol. 54, No. 1
In the report, Update: Influenza Activity - United States, 2004-05 Season, an error occurred on page 16 in the footnote linked to the bullet point, "Out-of-home caregivers and household contacts of persons with high-risk conditions†††." The footnote should read "Persons at high risk include adults aged >65 years, children aged 0-23 months, persons aged 2-64 years with underlying chronic medical conditions, women who will be pregnant during the influenza season, residents of nursing homes and long-term-care facilities, and children aged 2-18 years on chronic aspirin therapy."
- January 14, 2005
Update: Influenza Activity - United States, 2004-05 Season
Influenza activity was low in the United States during October through early December but has increased steadily since mid-December. Current surveillance indicators suggest that influenza activity for the season has not yet peaked. This report summarizes influenza activity during October 3, 2004-January 1, 2005* and provides information on the availability of additional influenza vaccine from GSK...
- January 7, 2005
Recommended Childhood and Adolescent Immunization Schedule - United States, 2005
Recommendations and format of the childhood and adolescent immunization schedule for July-December 2004 were approved by ACIP, the AAFP, and the AAP and were published in April 2004.The childhood and adolescent immunization schedule for 2005 is unchanged from that published in April 2004...
- January 2005 issue (Vol. 11, No. 1) HEPA/Vaccine Plan for Anthrax Remediation
In addition to killing 5 of its 11 victims, the 2001 anthrax attack on the U.S. Postal Service and federal facilities also contaminated a number of buildings. The U.S. government spent several hundred million dollars recovering buildings with large-area contamination by using chlorine dioxide fumigation...
Return to Immunization News main page
Non-CDC Link Disclaimer: Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. The CDC is not responsible for the content of the individual organization web pages found at these links.
Content Source: National Center for Immunization and Respiratory Diseases